PALATIN TECHNOLOGIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PALATIN TECHNOLOGIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $0 | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | $4.49M | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | $4.85M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $1.47M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($188.6K) | Sep 22, 2022 |
| FY2020 | Jun 30, 2020 | $0 | Sep 25, 2020 |
| FY2020 | Mar 31, 2020 | $0 | Sep 25, 2020 |
| FY2020 | Dec 31, 2019 | $21.0K | Sep 25, 2020 |
| FY2020 | Sep 30, 2019 | $97.0K | Sep 25, 2020 |
| FY2020 | Jun 30, 2019 | $60.27M | Sep 25, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($17.31M) | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | ($29.74M) | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | ($24.04M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($36.20M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($33.60M) | Sep 22, 2022 |
| FY2020 | Jun 30, 2020 | ($7.30M) | Sep 25, 2020 |
| FY2020 | Mar 31, 2020 | ($5.38M) | Sep 25, 2020 |
| FY2020 | Dec 31, 2019 | ($5.24M) | Sep 25, 2020 |
| FY2020 | Sep 30, 2019 | ($4.50M) | Sep 25, 2020 |
| FY2020 | Jun 30, 2019 | $52.22M | Sep 25, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($17.46M) | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | ($22.50M) | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | ($32.46M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($36.59M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($33.38M) | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | ($23.61M) | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $35.74M | Sep 25, 2020 |
| FY2019 | Jun 30, 2018 | $25.93M | Sep 12, 2019 |
| FY2020 | Jun 30, 2017 | $25.93M | Sep 25, 2020 |
| FY2018 | Jun 30, 2016 | ($49.25M) | Sep 13, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $14.90M | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | $22.40M | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | $22.63M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $21.33M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $12.93M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $13.96M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $14.86M | Sep 25, 2020 |
| FY2019 | Jun 30, 2018 | $32.57M | Sep 12, 2019 |
| FY2020 | Jun 30, 2017 | $32.57M | Sep 25, 2020 |
| FY2018 | Jun 30, 2016 | $43.07M | Sep 13, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.81M | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | $12.27M | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | $15.29M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $16.51M | Sep 28, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($21.31M) | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | ($31.46M) | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | ($29.27M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($29.92M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($93.6K) | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $41.33M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | ($21.78M) | Sep 25, 2020 |
| FY2020 | Jun 30, 2018 | $1.70M | Sep 25, 2020 |
| FY2019 | Jun 30, 2017 | $12.88M | Sep 12, 2019 |
| FY2018 | Jun 30, 2016 | ($47.36M) | Sep 13, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $0 | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | $42.5K | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | $433.9K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $261.4K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $5.7K | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $62.9K | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $36.1K | Sep 25, 2020 |
| FY2020 | Jun 30, 2018 | $22.5K | Sep 25, 2020 |
| FY2019 | Jun 30, 2017 | $133.4K | Sep 12, 2019 |
| FY2018 | Jun 30, 2016 | $17.7K | Sep 13, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.27M | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | $10.74M | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | $17.94M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $36.07M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $67.30M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $85.05M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $104.74M | Sep 25, 2020 |
| FY2019 | Jun 30, 2018 | $39.02M | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | $56.83M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | $10.86M | Sep 25, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $8.04M | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | $10.85M | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | $19.66M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $19.80M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $17.65M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | $4.88M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | $4.19M | Sep 25, 2020 |
| FY2019 | Jun 30, 2018 | $12.05M | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | $62.00M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | $28.44M | Sep 25, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($4.78M) | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | ($111.5K) | Sep 23, 2025 |
| FY2025 | Jun 30, 2023 | ($1.98M) | Sep 23, 2025 |
| FY2024 | Jun 30, 2022 | $16.27M | Sep 30, 2024 |
| FY2023 | Jun 30, 2021 | $49.65M | Sep 28, 2023 |
| FY2022 | Jun 30, 2020 | $80.17M | Sep 22, 2022 |
| FY2021 | Jun 30, 2019 | $100.55M | Sep 28, 2021 |
| FY2020 | Jun 30, 2018 | $26.96M | Sep 25, 2020 |
| FY2020 | Jun 30, 2017 | ($5.16M) | Sep 25, 2020 |
| FY2019 | Jun 30, 2016 | ($17.59M) | Sep 12, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($459.07M) | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | ($441.77M) | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | ($412.03M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($387.99M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($351.80M) | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | ($318.20M) | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | ($295.77M) | Sep 25, 2020 |
| FY2019 | Jun 30, 2018 | ($332.05M) | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | ($356.74M) | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | ($343.41M) | Sep 25, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.56M | Sep 23, 2025 |
| FY2024 | Jun 30, 2024 | $9.53M | Sep 30, 2024 |
| FY2023 | Jun 30, 2023 | $10.98M | Sep 28, 2023 |
| FY2022 | Jun 30, 2022 | $29.94M | Sep 22, 2022 |
| FY2022 | Jun 30, 2021 | $60.10M | Sep 22, 2022 |
| FY2022 | Jun 30, 2020 | $82.85M | Sep 22, 2022 |
| FY2021 | Jun 30, 2019 | $43.51M | Sep 28, 2021 |
| FY2020 | Jun 30, 2018 | $38.00M | Sep 25, 2020 |
| FY2020 | Jun 30, 2017 | $40.20M | Sep 25, 2020 |
| FY2019 | Jun 30, 2016 | $8.00M | Sep 12, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | (2) | Sep 30, 2024 |
| FY2024 | Jun 30, 2023 | (2) | Sep 30, 2024 |
| FY2020 | Jun 30, 2020 | 0 | Sep 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Sep 25, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Sep 25, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Sep 25, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Sep 25, 2020 |
| FY2020 | Mar 31, 2019 | 0 | Sep 25, 2020 |
| FY2020 | Dec 31, 2018 | 0 | Sep 25, 2020 |
| FY2020 | Sep 30, 2018 | 0 | Sep 25, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | (32) | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | (101) | Sep 23, 2025 |
| FY2020 | Jun 30, 2020 | 0 | Sep 25, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Sep 25, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Sep 25, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Sep 25, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Sep 25, 2020 |
| FY2020 | Mar 31, 2019 | 0 | Sep 25, 2020 |
| FY2020 | Dec 31, 2018 | 0 | Sep 25, 2020 |
| FY2020 | Sep 30, 2018 | 0 | Sep 25, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 929,597 | Sep 23, 2025 |
| FY2025 | Jun 30, 2024 | 358,532 | Sep 23, 2025 |
| FY2024 | Jun 30, 2023 | 11.66M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 9.27M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 9.20M | Sep 22, 2022 |
| FY2021 | Jun 30, 2020 | 229.26M | Sep 28, 2021 |
| FY2020 | Jun 30, 2019 | 226.82M | Sep 25, 2020 |
| FY2020 | Jun 30, 2018 | 200.55M | Sep 25, 2020 |
| FY2020 | Jun 30, 2017 | 160.52M | Sep 25, 2020 |
| FY2019 | Jun 30, 2016 | 68.57M | Sep 12, 2019 |